Drugs / Ifosfamid
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01481272 Background | Nov 2011 → Jul 2017 | diffuse large B-cell lymphoma | Polish Lymphoma Research Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ifosfamid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01481272 ↗ |
| Route | Intravenous | “1500mg/m2 or 1000mg/m2 (patients \>/=60 years), IV” NCT01481272 ↗ |